Morgan Stanley: First coverage of INNOSCIENCE (02577) with a "market perform" rating and a target price of HK$95.
This line believes that the current valuation largely reflects high market expectations.
Morgan Stanley has released a research report stating that it is initiating coverage on INNOSCIENCE (02577) for the first time with a rating in line with the market. The target price is 95 Hong Kong dollars, equivalent to a forecasted P/E ratio of 34 times for next year. The bank believes that INNOSCIENCE is a leading gallium nitride power integrated circuit manufacturer and that the company is well positioned to benefit from secular growth drivers such as artificial intelligence data centers, Siasun Robot & Automation, and electric vehicles. The bank believes that the current valuation largely reflects high market expectations.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
